Device Firms Get Extra Time To Remove Drug Codes From Product Labels
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration will allow some medical device packaging to continue to carry national drug code (NDC) or national health related item code (NHRIC) numbers until 2021, despite a regulation stating the codes need to be removed before then. The policy, laid out in a draft guidance released Feb. 2, will apply to certain devices manufactured and packaged before Sept. 24, 20181.
You may also be interested in...
FDA Guidance: Industry May Use Legacy Codes Until 2021
A final guidance document issued Aug. 30 will allow manufacturers to keep using legacy codes, such as National Health Related Item Codes and National Drug Code numbers, until Sept. 24, 2021. The agency previously indicated all legacy codes should be removed from device packaging by Sept. 24, 2018, at the latest.
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.